BDBM103791 US8551978, I-61::US8816088, I-61::US9394275, I-61::US9572802, Compound I-61::US9682957, I-61

SMILES: COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12

InChI Key: InChIKey=ODARRQMRLUNWHI-QLKFWGTOSA-N

Data: 5 KI  2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 103791   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance, Inc. US Patent					Assay Description Radioligand binding assay using muscarinic receptors.				US Patent US8551978 (2013) BindingDB Entry DOI: 10.7270/Q2Q81BPC
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company, LLC US Patent					Assay Description Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell me...				US Patent US8816088 (2014) BindingDB Entry DOI: 10.7270/Q2TQ6068
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	-14.2	n/a	n/a	n/a	n/a	n/a	n/a	37
Theravance Respiratory Company, LLC US Patent					Assay Description Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentr...				US Patent US9394275 (2016) BindingDB Entry DOI: 10.7270/Q2NS0SS8
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company LLC US Patent					Assay Description compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...				US Patent US9572802 (2017) BindingDB Entry DOI: 10.7270/Q2VH5QWS
					More data for this Ligand-Target Pair
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Respiratory Company, LLC US Patent					Assay Description Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...				US Patent US9682957 (2017) BindingDB Entry DOI: 10.7270/Q23776WR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	25
Theravance Respiratory Company, LLC US Patent					Assay Description cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...				US Patent US9682957 (2017) BindingDB Entry DOI: 10.7270/Q23776WR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM103791 (US8551978, I-61 | US8816088, I-61 | US9394275, I-6...) Show SMILES COc1cc(NC(=O)Cc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C49H51ClN6O8/c1-55(47(61)21-24-56-22-19-35(20-23-56)64-49(62)53-40-14-7-6-13-36(40)32-10-4-3-5-11-32)34-12-8-9-31(25-34)26-46(60)52-41-28-44(63-2)33(27-39(41)50)29-51-30-43(58)37-15-17-42(57)48-38(37)16-18-45(59)54-48/h3-18,25,27-28,35,43,51,57-58H,19-24,26,29-30H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t43-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	37
Theravance Respiratory Company, LLC US Patent					Assay Description cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...				US Patent US9394275 (2016) BindingDB Entry DOI: 10.7270/Q2NS0SS8
					More data for this Ligand-Target Pair